Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Rajesh Babu Medapati
Observed names:
Rajesh B Medapati,
Rajesh B. Medapati,
Rajesh babu Medapati,
Rajeshbabu Medapati
Institution:
Suven Life Sciences (India)
Observed institution:
Suven Life Sciences (India)
OpenAlex ID:
A5079038535
SUVN-502, a novel, potent, pure, and orally active 5-HT6 receptor antagonist: pharmacological, behavioral, and neurochemical characterization
2018
·
Ramakrishna Nirogi
, Renny Abraham
, et al.
·
Behavioural Pharmacology
·
39
Difference in the norepinephrine levels of experimental and non-experimental rats with age in the object recognition task
2012
·
Ramakrishna Nirogi
, Renny Abraham
, et al.
·
Brain Research
·
24
Discovery and Preclinical Characterization of Usmarapride (SUVN-D4010): A Potent, Selective 5-HT4 Receptor Partial Agonist for the Treatment of Cognitive Deficits Associated with Alzheimer’s Disease
2021
·
Ramakrishna Nirogi
, Abdul Rasheed Mohammed
, et al.
·
Journal of Medicinal Chemistry
·
19
Usmarapride (SUVN-D4010), a 5-HT4 receptor partial agonist for the potential treatment of Alzheimer's disease: Behavioural, neurochemical and pharmacological profiling
2023
·
Ramakrishna Nirogi
, Venkata Ramalingayya Grandhi
, et al.
·
European Journal of Pharmacology
·
10
Histamine 3 receptor inverse agonist Samelisant (SUVN-G3031): Pharmacological characterization of an investigational agent for the treatment of cognitive disorders
2021
·
Ramakrishna Nirogi
, Venkata R Grandhi
, et al.
·
Journal of Psychopharmacology
·
9
Ropanicant (SUVN-911), an α4β2 nicotinic acetylcholine receptor antagonist intended for the treatment of depressive disorders: pharmacological, behavioral, and neurochemical characterization
2022
·
Ramakrishna Nirogi
, Renny Abraham
, et al.
·
Psychopharmacology
·
8
P1‐310: Suvn‐g3031, an h3 receptor inverse agonist, produces procognitive effects without affecting sleep in preclinical models
2015
·
Vijay S. Benade
, Saivishal Daripelli
, et al.
·
Alzheimer s & Dementia
·
4
P1‐302: 5‐ht6 antagonist SUVN‐502 potentiates the procognitive and neurochemical effects of donepezil and memantine
2015
·
Pradeep Jayarajan
, Renny Abraham
, et al.
·
Alzheimer s & Dementia
·
2
Update on the Development of SUVN‐I6107: A True Positive Allosteric Modulator of the Muscarinic M1 Acetylcholine Receptor for the Treatment of Dementia
2025
·
Vijay Benade
, Anil Shinde
, et al.
·
Alzheimer s & Dementia
·
1
SUVN‐I6107: A True Positive Allosteric Modulator (PAM) at Muscarinic M1 Receptors for the Treatment of Cognitive Disorders
2023
·
Veera Raghava Chowdary Palacharla
, Naga Sai Soma Chandra Sekhar Guduru
, et al.
·
Alzheimer s & Dementia
·
1
PDF
SUVN‐I7016031: A Novel M1‐receptor Positive Allosteric Modulator (M1‐PAM) for the treatment of Parkinson's Disease Associated Dementia
2022
·
Venkata Ramalingayya Grandhi
, Narender Ganuga
, et al.
·
Alzheimer s & Dementia
·
1
PDF
SUVN‐I6107: A novel muscarinic M1 receptor‐positive allosteric modulator (M1‐PAM) for the treatment of cognitive deficits
2020
·
Renny Abraham
, Venkatesh Goura
, et al.
·
Alzheimer s & Dementia
·
1
PDF
[p1–120]: Novel Object Recognition Task: a Sensitive and Relevant Animal Model System for Evaluating Postmenopause‐related Dementia
2017
·
Ramalingayya Grandhi Venkata
, Joylee Fernandes
, et al.
·
Alzheimer s & Dementia
·
1
PDF
P1‐309: Suvn‐d4010: A novel 5‐ht4 receptor partial agonist for the treatment of Alzheimer's disease
2015
·
NageswaraRao Muddana
, Ramkumar Subramanian
, et al.
·
Alzheimer s & Dementia
·
1
Effect of a brain penetrant 5-HT7 receptor agonist LP-211 alone and in combination with gabapentin on cognitive deficits in insulin treated diabetic neuropathic rats
2025
·
Venkatesh Goura
, Pradeep Jayarajan
, et al.
·
Research Results in Pharmacology
Non‐clinical Efficacy and Safety of SUVN‐L3307032, a Muscarinic M4 Positive Allosteric Modulator (M4 PAM), for the Treatment of Neuropsychiatric Symptoms.
2025
·
Renny Abraham
, Venkatesh Goura
, et al.
·
Alzheimer s & Dementia
PDF
Efficacy of a Muscarinic (M1) Positive Allosteric Modulator, SUVN‐I7016031 in Animal Models of Dementia
2024
·
Renny Abraham
, Rajesh Babu Medapati
, et al.
·
Alzheimer s & Dementia
PDF
5‐HT1A Receptor Agonist, SUVN‐N9503012 for the Treatment of Dementia and Associated Neuropsychiatric Disorders
2023
·
Renny Abraham
, Surendra Petlu
, et al.
·
Alzheimer s & Dementia
PDF
Masupirdine (SUVN‐502): A pure 5‐HT6 receptor antagonist ameliorates aggression‐like behavior in animal models
2020
·
Jayaprakash Tadiparthi
, Narender Ganuga
, et al.
·
Alzheimer s & Dementia
PDF
P2‐083: Suvn‐502: a Pure 5‐ht6 Receptor Antagonist Ameliorates Senile Dementia in Animal Models
2019
·
Venkata Ramalingayya Grandhi
, Jayaprakash Tadiparthi
, et al.
·
Alzheimer s & Dementia
P3‐434: Suvn‐502: a Pure 5‐ht6 Receptor Antagonist Attenuates Memory Deficits Induced by Diverse Challenges
2019
·
Renny Abraham
, Rajesh Babu Medapati
, et al.
·
Alzheimer s & Dementia
PDF
P3‐042: Suvn‐502: a Pure 5‐ht6 Antagonist Potentiates the Effects of Donepezil or Memantine in Animal Models of Cognition, Neurochemistry and Electrophysiology
2019
·
Vijay Benade
, Gopinadh Bhyrapuneni
, et al.
·
Alzheimer s & Dementia
PDF
P2‐094: Suvn‐502: a Pure 5‐ht6 Receptor Antagonist Alleviates Post‐menopause Associated Dementia in Aged Menopause Wistar Rats
2018
·
Ramalingayya Grandhi Venkata
, Jayaprakash Tadiparthi
, et al.
·
Alzheimer s & Dementia
[p1–098]: Suvn‐502 (5‐ht6 Antagonist) Potentiates the Effects of Memantine in Animal Models of Cognition
2017
·
Ramakrishna Nirogi
, Renny Abraham
, et al.
·
Alzheimer s & Dementia
P3‐135: SUVN‐I4035 ‐ Preclinical Characterization of Novel Muscarinic M1 Positive Allosteric Modulator
2016
·
Renny Abraham
, Anil K. Shinde
, et al.
·
Alzheimer s & Dementia
Show more works
View as search
Works count:
26
Citation count:
121
H-index:
6
I10-index:
4
Year
Topic
Type